Laobaixing Pharmacy announces 2025 half-year earnings briefing

Laobaixing Pharmacy Chain Co., Ltd. has announced its 2025 half-yearly earnings briefing, scheduled for September 29, 2025, from 10:00 to 11:30 AM. The online event will be held via the Shanghai Stock Exchange Roadshow Center, offering video streaming and interactive Q&A sessions. This briefing follows the disclosure of the company's 2025 half-year report on August 26, 2025, and aims to provide investors with a deeper understanding of its financial status and operating achievements.

Key attendees from Laobaixing Pharmacy will include chairman and president Xie Zilong, independent directors Wu Lianfeng, Xie Ziqi, and Ren Mingchuan, chief financial officer Chen Lishan, and board secretary Feng Shini. Investors are encouraged to submit questions in advance between September 22 and September 26, 2025, 4:00 PM, either through the "Question Pre-collection" section on the roadshow website or by emailing ir@lbxdrugs.com.

The company's securities affairs department can be reached at 0731-84035189 or ir@lbxdrugs.com for any inquiries. A visual summary of the 2025 half-yearly report is also available via a WeChat QR code for convenient viewing.